Literature DB >> 16454381

Feline immunodeficiency virus testing in stray, feral, and client-owned cats of Ottawa.

Susan E Little1.   

Abstract

Feline immunodeficiency virus (FIV) seroprevalence is evaluated in 3 groups of cats. Seventy-four unowned urban strays were tested, as well as 20 cats from a small feral cat colony, and 152 client-owned cats. Of the 246 cats tested, 161 (65%) were male and 85 (35%) were female. Seroprevalence for FIV was 23% in the urban strays, 5% in the feral cat colony, and 5.9% in the client-owned cats. Ten cats (4%) were also positive for Feline leukemia virus (FeLV) antigen, including 2 cats coinfected with FeLV and FIV. Seroprevalence for FIV in cats from Ottawa is similar to that found in other nonrandom studies of cats in North America.

Entities:  

Mesh:

Year:  2005        PMID: 16454381      PMCID: PMC1255591     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  20 in total

1.  Feline immunodeficiency virus infection in cats of Japan.

Authors:  T Ishida; T Washizu; K Toriyabe; S Motoyoshi; I Tomoda; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

2.  Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats.

Authors:  Julie K Levy; P Cynda Crawford; Margaret R Slater
Journal:  J Am Vet Med Assoc       Date:  2004-11-15       Impact factor: 1.936

3.  Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E.

Authors:  Y Inoshima; T Miyazawa; M Kohmoto; Y Ikeda; E Sato; T Hohdatsu; C Mathiason-Dubard; E A Hoover; T Mikami
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

Review 4.  Feline immunodeficiency virus: an epidemiological review.

Authors:  F Courchamp; D Pontier
Journal:  C R Acad Sci III       Date:  1994-12

5.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

6.  Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.

Authors:  D L Sodora; E G Shpaer; B E Kitchell; S W Dow; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Prevalence of feline immunodeficiency virus in submissions of feline serum to a diagnostic laboratory in Atlantic Canada.

Authors:  M E Hitt; L Spangler; C McCarville
Journal:  Can Vet J       Date:  1992-11       Impact factor: 1.008

8.  Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, Canada.

Authors:  F Reggeti; D Bienzle
Journal:  J Gen Virol       Date:  2004-07       Impact factor: 3.891

9.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

Review 10.  FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.

Authors:  E W Uhl; T G Heaton-Jones; R Pu; J K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2002-12       Impact factor: 2.046

View more
  13 in total

1.  Naturally acquired feline immunodeficiency virus (FIV) infection in cats from western Canada: Prevalence, disease associations, and survival analysis.

Authors:  Madhu Ravi; Gary A Wobeser; Susan M Taylor; Marion L Jackson
Journal:  Can Vet J       Date:  2010-03       Impact factor: 1.008

2.  Concomitant feline immunodeficiency virus (FIV) and Mycoplasma haemofelis in a barn cat.

Authors:  Alejandra Ceballos-Vasquez
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

Review 3.  Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management.

Authors:  Susan Little; Dorothee Bienzle; Lisa Carioto; Hugh Chisholm; Elizabeth O'Brien; Margie Scherk
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

Review 4.  Infection and cancer in multicellular organisms.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

5.  Toxoplasma gondii, Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in northwest China: co-infections and risk factors.

Authors:  Wei Cong; Qing-Feng Meng; Radu Blaga; Isabelle Villena; Xing-Quan Zhu; Ai-Dong Qian
Journal:  Parasitol Res       Date:  2015-09-12       Impact factor: 2.289

6.  Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in Canada.

Authors:  Susan Little; William Sears; Jessica Lachtara; Dorothee Bienzle
Journal:  Can Vet J       Date:  2009-06       Impact factor: 1.008

7.  An Examination of an Iconic Trap-Neuter-Return Program: The Newburyport, Massachusetts Case Study.

Authors:  Daniel D Spehar; Peter J Wolf
Journal:  Animals (Basel)       Date:  2017-10-31       Impact factor: 2.752

8.  Risk of Feline Immunodeficiency Virus (FIV) Infection in Pet Cats in Australia is Higher in Areas of Lower Socioeconomic Status.

Authors:  Vivian Tran; Mark Kelman; Michael Ward; Mark Westman
Journal:  Animals (Basel)       Date:  2019-08-21       Impact factor: 2.752

9.  Survey of infectious and parasitic diseases in stray cats at the Lisbon Metropolitan Area, Portugal.

Authors:  Ana Duarte; Isabel Castro; Isabel M Pereira da Fonseca; Virgilio Almeida; Luis M Madeira de Carvalho; José Meireles; Maria I Fazendeiro; Luis Tavares; Yolanda Vaz
Journal:  J Feline Med Surg       Date:  2010-05-13       Impact factor: 2.015

10.  Cats Are Not Fish: A Ricker Model Fails to Account for Key Aspects of Trap-Neuter-Return Programs.

Authors:  Peter J Wolf; Rachael E Kreisler; Julie K Levy
Journal:  Animals (Basel)       Date:  2021-06-28       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.